Treatment of Radiation Nephropathy with ACE Inhibitors and AII Type-1 and Type-2 Receptor Antagonists

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|13|1317-1325

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.13, 2007-05, pp. : 1317-1325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE Inhibitors and AII Receptor Antagonists in the Treatment and Prevention of Bone Marrow Transplant Nephropathy

By  

Current Pharmaceutical Design, Vol. 9, Iss. 9, 2003-04 ,pp. : 737-749

Bentham Science Publishers

Access to resources Recommend Favorite

Do ACE Inhibitors/Angiotensin II Type 1 Receptor Antagonists Reduce Hospitalisations in Older Patients with Heart Failure?: A Propensity Analysis

By Trewet CoraLynn B.   Shireman Theresa I.   Rigler Sally K.   Howard Patricia A.  

Drugs & Aging, Vol. 24, Iss. 11, 2007-01 ,pp. : 945-955

Adis International

Access to resources Recommend Favorite

Class benefits of AT1 antagonists in Type 2 diabetes with nephropathy

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 625-628

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes

By Komers R.   Komersova K.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2601-2617

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Essential Hypertension

By Smith David H.G.  

Drugs, Vol. 68, Iss. 9, 2008-01 ,pp. : 1207-1225

Adis International

Access to resources Recommend Favorite